Lack of antiviral activity of darunavir against SARS-CoV-2-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lack of antiviral activity of darunavir against SARS-CoV-2

Published:2020-08 Issue: Volume:97 Page:7-10
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

De Meyer Sandra,Bojkova Denisa,Cinatl Jindrich,Van Damme Ellen,Buyck Christophe,Van Loock Marnix,Woodfall Brian,Ciesek Sandra

Funder

Janssen Pharmaceuticals

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference21 articles.

1. Covid-19 — the search for effective therapy;Baden;N Engl J Med,2020

2. SARS-CoV-2 infected host cell proteomics reveal potential therapy targets, [Under review];Bojkova;Nature,2020

3. Week 48 analysis of once-daily vs. twice-daily darunavir/ritonavir in treatment-experienced HIV-1-infected patients;Cahn;AIDS,2011

4. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19;Cao;N Engl J Med,2020

5. Chang Y-C, Tung Y-A, Lee K-H, Chen T-F, Hsiao Y-C, Chang H-C, et al. Potential therapeutic agents for COVID-19 based on the analysis of protease and RNA polymerase docking. Preprints (www.preprints.org) 2020. https://doi.org/10.20944/preprints202002.0242.v1.

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plausible mechanism of drug resistance and side-effects of COVID-19 therapeutics: a bottleneck for its eradication;DARU Journal of Pharmaceutical Sciences;2024-07-19

2. Human transferrin receptor can mediate SARS-CoV-2 infection;Proceedings of the National Academy of Sciences;2024-02-26

3. Preclinical and Clinical Investigations of Potential Drugs and Vaccines for COVID-19 Therapy: A Comprehensive Review With Recent Update;Clinical Pathology;2024-01

4. Insights on Various Antiviral Drugs for Treating Patients with COVID-19;Livestock Diseases and Management;2024

5. An Update on SARS-CoV-2 Clinical Trial Results—What We Can Learn for the Next Pandemic;International Journal of Molecular Sciences;2023-12-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3